True is all about building relationships with the brightest minds and most interesting people. Let's talk.
As a Partner at True, Stephanie specializes in Board and C-suite Life Sciences searches. Her 20 year career working with public, VC & PE backed Biopharmaceutical, Medical Device and Diagnostics organizations spans all phases of R&D, commercial, technical operations and regulatory.
Stephanie has worked with market leaders pursuing transformative small molecules, biologics, and gene modification technologies including approaches in p53 regulators, checkpoint inhibitors, CRISPR/Cas9, RNA, viral gene and adoptive cell therapies, in addition to metagenomics derived gene editing systems. Her record of working with disruptive technologies extends to Genomics approaches leveraging next-gen DNA sequencing and synthesis, and Digital therapeutics.
Stephanie joins True following a progression of roles in the global life science practices of Korn Ferry, Spencer Stuart, and boutique executive search firms. Her professional career started in the Healthcare Consulting practice of Cap Gemini/Ernst & Young. She is a graduate of Boston College and Emory University, where she completed a dual Masters in Business Administration at the Goizueta School of Business and Health Policy & Management at the Rollins School of Public Health.